What's new

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Feb 26, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Here's Your First Look At Lewis Hamilton Ripping Fast Laps In His New Ferrari

Next Article

A Tesla Model 3 For $23,000?

Related Posts

Human medicines European public assessment report (EPAR): Galvus, vildagliptin, Date of authorisation: 25/09/2007, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): CoAprovel, irbesartan,hydrochlorothiazide, Date of authorisation: 14/10/1998, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 11, 2025  0

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0